UNRESECTABLE LIPOSARCOMA
Clinical trials for UNRESECTABLE LIPOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE LIPOSARCOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE LIPOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug BTX-A51 tested in rare sarcomas
Disease control OngoingThis early study tests an oral drug called BTX-A51 in 24 people with advanced liposarcoma (a type of fat tissue cancer) that has spread or come back. The main goal is to see if the drug is safe and tolerable at different doses. It focuses on specific genetic subtypes: MDM2-amplif…
Matched conditions: UNRESECTABLE LIPOSARCOMA
Phase: PHASE1 • Sponsor: Michael Wagner, MD • Aim: Disease control
Last updated Jul 02, 2026 04:00 UTC
-
New drug cocktail shows promise against rare sarcomas
Disease control OngoingThis study tests whether adding the targeted drug cabozantinib to immunotherapy (ipilimumab and nivolumab) works better than immunotherapy alone for people with advanced soft tissue sarcoma that has spread. About 66 adults with specific sarcoma types will take part. The goal is t…
Matched conditions: UNRESECTABLE LIPOSARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute LAO • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC